Shareholding for the Period Ended March 31, 2017
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here06-04-2017
06-04-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Chemo Pharma Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201623-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Chemo Pharma Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.14-01-2017
Closure of Trading Window
Chemo Pharma Laboratories Ltd has informed BSE regarding "Closure of Trading Window".12-01-2017
Shareholding for the Period Ended December 31, 2016
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here10-01-2017
Board Meeting Intimation for Results
Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on January 23, 2017, to transact the following business:1. To consider and approve the Un-Audited Financial Results for the quarter ended December 31, 2016.2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended December 31, 2016.09-01-2017
Outcome of Board Meeting
Chemo Pharma Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 24, 2016, inter alia, has approved the following:- The Board took on record the intimation for Trading Window pursuant to regulations of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992.24-10-2016
Standalone Financial Results, Limited Review Report for September 30, 2016
Chemo Pharma Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 201624-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Chemo Pharma Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-10-2016